SecProbe.io

CORRESP
1
filename1.htm

August
10, 2023

VIA
EDGAR

    United
    States Securities and Exchange Commission

    Division
    of Corporation Finance

    100
    F Street, N.E.

    Mail
    Stop 4546

    Washington,
    D.C. 20549

    Attn:
    Ms.
    Lauren Hamill

    Re:
    Evofem
    Biosciences, Inc.

    Registration
    Statement on Form S-1

    File
    No. 333-273185

Acceleration
Request

Requested
Date: Monday, August 14, 2023

Requested
Time: 4:30 P.M. Eastern Time

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”)
hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause
the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) to become effective
on August 14, 2023, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant
may orally request via telephone call to the staff (the “Staff”). This request for acceleration is subject,
however, to your receiving a telephone call prior to such time from our legal counsel, Procopio, Cory, Hargreaves & Savitch LLP,
confirming this request. The Registrant hereby authorizes each of Dennis Doucette of Procopio, Cory, Hargreaves & Savitch LLP, counsel
to the Registrant, to make such request on its behalf.

Once
the Registration Statement has been declared effective, please orally confirm that event with Dennis Doucette of Procopio, Cory, Hargreaves
& Savitch LLP, counsel to the Registrant, at (858) 720-6322.

In
connection with this request, the Registrant acknowledges that:

    ●
    should
    the Commission or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose
    the Commission from taking any action with respect to the Registration Statement;

    ●
    the
    action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective,
    does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration
    Statement; and

    ●
    the
                                            Registrant may not assert Staff comments and the declaration of effectiveness as a defense
                                            in any proceeding initiated by the Commission or any person under the federal securities
                                            laws of the United States.

    Very truly yours,

    Evofem Biosciences, Inc.

    By:
    /s/
    Saundra Pelletier

    Saundra Pelletier

    Chief Executive Officer

    - 1 -